Search hospitals > Florida > Fort Lauderdale
UM Sylvester Comprehensive Cancer Center at Plantation
Claim this profileFort Lauderdale, Florida 33324
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Lung Cancer
Conducts research for Breast Cancer
Conducts research for Tumors
93 reported clinical trials
41 medical researchers
Summary
UM Sylvester Comprehensive Cancer Center at Plantation is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Cancer, Recurrence, Lung Cancer, Breast Cancer, Tumors and other specialties. UM Sylvester Comprehensive Cancer Center at Plantation is involved with conducting 93 clinical trials across 208 conditions. There are 41 research doctors associated with this hospital, such as Jose Lutzky, MD, Marilyn Huang, Macarena I. De La Fuente, and Aman Chauhan, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Recurrence
Global LeaderStage IV
Stage III
IDH positive
Top PIs
Jose Lutzky, MDUniversity of Miami3 years of reported clinical research
Expert in Melanoma
Studies Cancer
20 reported clinical trials
40 drugs studied
Marilyn HuangUniversity of Miami3 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
13 reported clinical trials
39 drugs studied
Macarena I. De La FuenteUniversity of Miami Miller School of Medicine-Sylvester Cancer Center5 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
12 reported clinical trials
27 drugs studied
Aman Chauhan, MDUniversity of Kentucky/Markey Cancer Center2 years of reported clinical research
Studies Neuroendocrine Tumors
Studies Cancer
11 reported clinical trials
20 drugs studied
Clinical Trials running at UM Sylvester Comprehensive Cancer Center at Plantation
Breast Cancer
Cancer
Melanoma
Lung Cancer
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Cutaneous Melanoma
Gallbladder Cancer
Skin Cancer
Merkel Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at UM Sylvester Comprehensive Cancer Center at Plantation?
UM Sylvester Comprehensive Cancer Center at Plantation is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Cancer, Recurrence, Lung Cancer, Breast Cancer, Tumors and other specialties. UM Sylvester Comprehensive Cancer Center at Plantation is involved with conducting 93 clinical trials across 208 conditions. There are 41 research doctors associated with this hospital, such as Jose Lutzky, MD, Marilyn Huang, Macarena I. De La Fuente, and Aman Chauhan, MD.